Protagonist Therapeutics, Inc (PTGX) Financials
Key financial figures for Protagonist Therapeutics, Inc (Q1 2026).
- Revenue
- $56M
- Net Income
- $4M
- EPS
- $0.06
- Total Assets
- $697M
- Operating Cash Flow
- -$49M
Full income statement, balance sheet, and cash flow for Protagonist Therapeutics, Inc on SentiSense.